BIOSCIENCE INT INC has a total of 18 patent applications. Its first patent ever was published in 1987. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are APPLIED GENOMICS INC, COMMW SERUM LAB COMMISSION and EIRX THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 3 | |
#3 | Australia | 2 | |
#4 | Denmark | 2 | |
#5 | Finland | 2 | |
#6 | Norway | 2 | |
#7 | New Zealand | 2 | |
#8 | Ireland | 1 | |
#9 | Portugal | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Unspecified technologies | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Hermon-Taylor John | 15 |
#2 | Mcfadden John-Jo | 7 |
#3 | Austen Brian Maxwell | 4 |
#4 | Austen Maxwell | 2 |
#5 | Hermon-Taylor John Dept Of Sur | 2 |
#6 | Austen Brian M | 2 |
#7 | Austen Brian Maxwell Dept Of S | 1 |
#8 | Mcfadden John-Jo Dept Of Surge | 1 |
Publication | Filing date | Title |
---|---|---|
US5225324A | Diagnostics for mycobacteria in public health, medical, and veterinary practice | |
US5356781A | Zymogen activation peptides (ZAP) in the diagnosis of disease | |
EP0356450A1 | Diagnostics and vaccines for mycobacteria in public health, medical and veterinary practice | |
PT86603A | Diagnosis of pancreatic disease - by assaying body fluid for activation peptide(s) of pancreatic zymogen(s) specifically cleaved by proteolysis during activation | |
US4948723A | Method of diagnosis and severity-assessment of pancreatic disease | |
IE872014L | Diagnosis severity prediction and monitoring of disease by immunoassay of free activation peptides of pancreatic zymogens |